AdipoGen Life Sciences
Innovative and high quality products focusing on advanced inflammation, immune response & immunometabolic research
AdipoGen Life Sciences, Inc. is a well-established manufacturer and worldwide distributor of innovative and high quality products focusing on advanced inflammation, immune response & immunometabolic research. Production is located in Switzerland, the US and Germany. A motivated team of highly-skilled individuals develops and manufactures new products for the life science research market. They focus their efforts on inflammation and immune response, including inflammasomes, innate immunity, B- and T-cells immune regulation, neuroinflammation, obesity, immuno-oncology and COVID-19 research. AdipoGen Life Sciences owns chemical laboratories, enabling the company to isolate unique natural products, to develop new and innovative small molecules, and to manufacture rare antibiotics.
Bio-Connect Life Sciences supplies all their products in the Benelux. If you have any questions, please contact the helpdesk.
Major product lines from AdipoGen Life Sciences
- Antibodies (Special focus: functional antibodies & recombinant antibodies (Non-animal source))
- Recombinant proteins
- ELISA kits & matched pair detection sets
- Small molecules (biochemicals) / natural products / rare antibiotics
New highly specific SARS-CoV-2 Neutralizing Antibodies Detection Kit
Publications with products by AdipoGen Life Sciences
- Haselmayer P, Vigolo M, Nys J, Schneider P, Hess H. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells. Eur J Immunol. 2017;47(6):1075-1085.
- Kowalczyk-Quintas C, Schuepbach-Mallepell S, Vigolo M, et al. Antibodies that block or activate mouse b cell activating factor of the tumor necrosis factor (Tnf) family (Baff), respectively, induce b cell depletion or b cell hyperplasia. J Biol Chem. 2016;291(38):19826-19834.
- Eslami M, Meinl E, Eibel H, et al. Baff 60-mer, and differential baff 60-mer dissociating activities in human serum, cord blood and cerebrospinal fluid. Front Cell Dev Biol. 2020;8:577662.
- Kume M, Kiyohara E, Matsumura Y, et al. Ganglioside gd3 may suppress the functional activities of benign skin t cells in cutaneous t-cell lymphoma. Front Immunol. 2021;12:651048.
- Singh K, Kadesjö E, Lindroos J, et al. Interleukin-35 administration counteracts established murine type 1 diabetes–possible involvement of regulatory T cells. Sci Rep. 2015;5:12633.
- Ellisdon AM, Nold-Petry CA, D’Andrea L, et al. Homodimerization attenuates the anti-inflammatory activity of interleukin-37. Sci Immunol. 2017;2(8).
- Ising C, Venegas C, Zhang S, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669-673.
- Müller K, Girl P, von Buttlar H, Dobler G, Wölfel R. Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2. J Virol Methods. 2021;292:114122.
- Zheng M, Karki R, Vogel P, Kanneganti T-D. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell. 2020;181(3):674-687.e13.
- Sellami L, Rucheton B, Ben Younes I, et al. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience. Neurobiol Aging. 2020;91:167.e1-167.e9.
- Schneider KS, Groß CJ, Dreier RF, et al. The inflammasome drives gsdmd-independent secondary pyroptosis and il-1 release in the absence of caspase-1 protease activity. Cell Rep. 2017;21(13):3846-3859.